Actuate Therapeutics Ownership | Who Owns Actuate Therapeutics?

Actuate Therapeutics Ownership Summary

Actuate Therapeutics is owned by 58.11% institutional investors, 16.14% insiders, and 25.75% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 51.15% of ACTU shares.

ACTU Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Actuate Therapeutics	58.11%	16.14%	25.75%
Sector	Healthcare Stocks	42.50%	10.81%	46.69%
Industry	Biotech Stocks	45.24%	10.75%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bios capital management, lp	10.05M	51.15%	$67.23M
Vanguard group	316.01K	1.61%	$2.11M
Voss capital	286.14K	1.46%	$1.75M
Blackrock funding, inc. /de	282.07K	1.44%	$1.89M
Geode capital management	145.41K	0.74%	$972.80K
Northern trust	85.45K	0.43%	$571.69K
State street	49.90K	0.25%	$333.80K
Northwestern mutual wealth management	19.30K	0.10%	$129.12K
Gleason group	19.03K	0.10%	$127.30K
Sfmg	17.00K	0.09%	$113.73K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bios capital management, lp	10.05M	75.62%	$67.23M
Voss capital	286.14K	0.12%	$1.75M
Northwestern university	6.49K	0.08%	$43.41K
Gleason group	19.03K	0.01%	$127.30K
Sfmg	17.00K	0.01%	$113.73K
Freestone capital	10.00K	0.00%	$66.90K
Prosight management, lp	885.00	0.00%	$5.92K
Global retirement partners	6.25K	0.00%	$41.81K
Tower research capital llc (trc)	1.64K	0.00%	$10.99K
Wealthspire advisors	5.00K	0.00%	$33.45K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	282.07K	-	86.62K
Bios capital management, lp	10.05M	75.62%	84.92K
Vanguard group	316.01K	-	51.55K
Geode capital management	145.41K	0.00%	27.36K
State street	49.90K	-	18.48K

Top Sellers

Holder	Shares	% Assets	Change
Barclays	8.87K	-	-28.47K
Sigma planning	-	-	-23.68K
Northwestern university	6.49K	0.08%	-21.29K
Mercer global advisors inc /adv	-	-	-16.34K
Marshall wace, llp	-	-	-16.11K

New Positions

Holder	Shares	% Assets	Change	Value
Wealthspire advisors	5.00K	0.00%	5.00K	$33.45K
Prosight management, lp	885.00	0.00%	885.00	$5.92K
Russell investments group	487.00	-	487.00	$3.26K
Pnc financial services group	384.00	-	384.00	$2.57K
Eversource wealth advisors	70.00	-	70.00	$469.00

Sold Out

Holder	Change
Tang capital management	-5.24K
Chicago partners investment group	-10.37K
Kg&l capital management	-12.00K
Marshall wace, llp	-16.11K
Mercer global advisors inc /adv	-16.34K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	42	10.53%	11,416,022	1.77%	58	1.76%	21	-36.36%	12	500.00%
Jun 30, 2025	37	48.00%	11,216,230	7.83%	57	2.02%	32	68.42%	2	100.00%
Mar 31, 2025	25	31.58%	10,401,592	2.82%	53	0.37%	19	35.71%	1	-50.00%
Dec 31, 2024	19	90.00%	10,116,136	2547.05%	120	960.02%	14	40.00%	2	-
Sep 30, 2024	10	-	382,167	-	3	-	10	-	-	-

Recent Insider Transactions

Date	Name	Activity	Value
Jun 27, 2025	Bios Equity COF, LP	Buy	$500.00K
Jun 27, 2025	Bios Equity COF, LP	Buy	$500.00K
Jun 27, 2025	Kreis Leslie W.	Buy	$500.00K
Jun 27, 2025	Kreis Leslie W.	Buy	$500.00K
Jun 27, 2025	Fletcher Aaron G.L.	Buy	$500.00K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2014 Q2	-	-
2013 Q2	-	-
2012 Q4	-	-
2012 Q2	-	-

ACTU Ownership FAQ

Who Owns Actuate Therapeutics?

Actuate Therapeutics shareholders are primarily institutional investors at 58.11%, followed by 16.14% insiders and 25.75% retail investors. The average institutional ownership in Actuate Therapeutics's industry, Biotech Stocks , is 45.24%, which Actuate Therapeutics exceeds.

Who owns the most shares of Actuate Therapeutics?

Actuate Therapeutics’s largest shareholders are Bios capital management, lp (10.05M shares, 51.15%), Vanguard group (316.01K shares, 1.61%), and Voss capital (286.14K shares, 1.46%). Together, they hold 54.22% of Actuate Therapeutics’s total shares outstanding.

Does Blackrock own Actuate Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Actuate Therapeutics.

Who is Actuate Therapeutics’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Actuate Therapeutics’s biggest shareholder by percentage of total assets invested, with 75.62% of its assets in 10.05M Actuate Therapeutics shares, valued at 67.23M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools